News for 'US Generics'

Dr Reddy's scouting for partners in Japan

Dr Reddy's scouting for partners in Japan

Rediff.com18 Aug 2010

Drug maker Dr Reddy's Laboratories on Wednesday said it was looking out for partnerships to expand its presence in Japan.

Patent office rejects Roche claim on eye drug

Patent office rejects Roche claim on eye drug

Rediff.com6 May 2010

Swiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its claim over Valcyte (valganciclovir).

India-EU ministerial on FTA likely in June-July

India-EU ministerial on FTA likely in June-July

Rediff.com4 May 2010

A senior European Union representative said here on Tuesday that the body would soon change its Customs laws to address the issue of seizures of Indian generic drug shipments while en route for export to other countries.

Cipla's brilliant plan to make it big in the US

Cipla's brilliant plan to make it big in the US

Rediff.com5 Sep 2015

Cipla, though late in changing its strategy for international markets, has in recent years taken an inorganic route for expansion.

Wockhardt launches prostate drug in US market

Wockhardt launches prostate drug in US market

Rediff.com28 Apr 2010

Pharma major Wockhardt on Wednesday said it has launched Tamsulosin capsules, indicated for problem of prostate enlargement, in the US market on the day one of the expiry of patent covering the drug.

Dr Reddy's recalls Risperidone tablets in US

Dr Reddy's recalls Risperidone tablets in US

Rediff.com16 Apr 2010

Pharma major Dr Reddys Laboratories has voluntarily recalled 78,876 bottles of 2mg and 4mg Risperidone, generic version of Resperdal, tablets in the United States.

Pharma 2009: No medicine to cure adversity

Pharma 2009: No medicine to cure adversity

Rediff.com22 Dec 2009

The year also witnessed Mumbai-based Sun Pharmaceutical continue the tussle for taking over Israeli drug firm Taro, while MNCs struck alliances with Indian companies to capitalise on generics expertise in New Delhi.

Gone Kesh Review: Bald & beautiful

Gone Kesh Review: Bald & beautiful

Rediff.com29 Mar 2019

Gone Kesh is a good-natured coming-of-age tale, applauds Sukanya Verma.

US healthcare Bill: Gains for Indian pharma

US healthcare Bill: Gains for Indian pharma

Rediff.com26 Mar 2010

Opportunities will also stem from the clear support for generics.

Pharma cos ready to meet Tamiflu demand

Pharma cos ready to meet Tamiflu demand

Rediff.com12 Aug 2009

The central government's decision to stockpile another 20 million capsules of generic Tamiflu (Oseltamivir) to strengthen its preparedness to fight the H1N1 epidemic has alerted domestic pharmaceutical companies.

US firm drags Lupin to court

US firm drags Lupin to court

Rediff.com19 Mar 2010

Cephalon, a US-based drug maker, has filed a lawsuit against Lupin Ltd and its US subsidiary Lupin Pharmaceuticals for challenging the patents on its sleep disorder drug Nuvigil.

BJP releases Gujarat manifesto on the eve of voting

BJP releases Gujarat manifesto on the eve of voting

Rediff.com8 Dec 2017

Unlike the 2012 manifesto, the BJP has chosen not to make any extravagant promises.

RIL likely to go slow on pharma, healthcare

RIL likely to go slow on pharma, healthcare

Rediff.com18 Jun 2010

Plans to set up an integrated pharma firm in a phased manner.

No cure in sight for India-EU drug seizure issue

No cure in sight for India-EU drug seizure issue

Rediff.com16 Nov 2009

India and the European Union (EU) have begun discussions to resolve the ongoing dispute over the seizure of Indian generic drugs consignments in transit at European ports. Lutz Guellner, spokesperson for the European Trade Commissioner, told Business Standard that a meeting of the EU-India Joint Customs Cooperation Committee held in New Delhi on Thursday proved "constructive" with an "open discussion of the issues" taking place.

US stops launch of Dr Reddy's drug

US stops launch of Dr Reddy's drug

Rediff.com14 Jun 2010

Dr Reddy's Laboratories received a major setback in the US, as a court there granted a motion seeking a preliminary injunction to block the launch of its generic version of Sanofi-Aventis' anti-allergic drug, Allegra D24.

What Modi can do to tackle slowdown

What Modi can do to tackle slowdown

Rediff.com1 Nov 2019

'Event management can distract from, but not permanently mask, execution failures,' points out Rathin Roy, director, National Institute of Public Finance and Policy.

7 most popular SUVs in India

7 most popular SUVs in India

Rediff.com13 May 2010

Early SUVs were descendants from commercial and military vehicles such as the World War II Jeep and Land Rover.

8 simple tips to write your first CV

8 simple tips to write your first CV

Rediff.com13 Jan 2020

Your resume should generate curiosity into your profile as a person and set you apart from your peers, says Achin Bhattacharyya.

Indian drug makers maintain pace of US mktg nod

Indian drug makers maintain pace of US mktg nod

Rediff.com4 Jan 2010

This increase is despite the decreased growth of drug sales in the US - the world's largest market - which has seen a tightening of regulations and aggressive competition.

Now, loans for all your lifestyle needs

Now, loans for all your lifestyle needs

Rediff.com4 Dec 2019

You can get a lumpsum sanctioned, but you may draw only part of it and pay interest on the amount used.

Good future for Indian pharma

Good future for Indian pharma

Rediff.com7 Apr 2010

The future looks somewhat bright for the Indian pharmaceutical industry which is wholly into generics. It expects to get a push from the new US legislation bringing into the health-care fold 32 million or 10 per cent of the country's population which is currently uninsured.

'India's patent policy is discouraging innovation'

'India's patent policy is discouraging innovation'

Rediff.com30 Mar 2010

US-based Eli Lilly has planned to continue its focus on innovation-driven products, instead of opening up to opportunities in off-patent generic drugs, being tapped by its larger competitors like GSK and Pfizer.

Sops for drug exporters avoiding Europe

Sops for drug exporters avoiding Europe

Rediff.com25 Nov 2009

The Department of Pharmaceuticals has submitted a freight subsidy scheme for exporters to the Commerce Ministry so that they could take alternate routes and avoid transit through Europe, which is a shorter route with better connectivity.

Pharma: Remove duties on life saving drugs

Pharma: Remove duties on life saving drugs

Rediff.com8 Feb 2010

We don't expect any big changes in on excise duty and custom duty rates, except in life saving drugs.

How Saridon has managed to remain top of the mind

How Saridon has managed to remain top of the mind

Rediff.com3 May 2019

What has worked though for Brand Saridon has been its single-minded focus on headaches as opposed to other analgesics that dwell on a wider set of problems, reports Sohini Das.

Fake 'Made-in-India' drugs exported from China

Fake 'Made-in-India' drugs exported from China

Rediff.com11 Jun 2009

'Taking serious note of the action by unscrupulous elements to malign the Indian generic pharma industry, the embassy of India, Beijing, has been requested to lodge a strong protest with concerned Chinese authorities and also to impress upon them to take stringent action against such unscrupulous elements,' a commerce ministry statement said in New Delhi.

Government decides to allow retail sale of Tamiflu

Government decides to allow retail sale of Tamiflu

Rediff.com14 Sep 2009

The government today decided to allow retail sale of Oseltamivir, commonly known as Tamiflu, the only drug available to treat swine flu.

The US healthcare opportunity for Indian firms

The US healthcare opportunity for Indian firms

Rediff.com9 Apr 2010

The US healthcare reform bill with its focus on cutting costs is likely to be beneficial for generic and CRAMS players.

Pfizer sues Sun, Wockhardt, Lupin in US

Pfizer sues Sun, Wockhardt, Lupin in US

Rediff.com6 May 2009

Pfizer, the world's largest pharmaceutical company, has filed patent infringement suits against Sun Pharma, Wockhardt Ltd and Lupin Ltd to prevent these companies from securing marketing approvals for the generic equivalents of its high-selling neuropathic pain management drug Lyrica in the United States.

Sanjay Valvani, New York hedge fund exec found dead in apparent suicide

Sanjay Valvani, New York hedge fund exec found dead in apparent suicide

Rediff.com22 Jun 2016

Prosecutors unveiled charges against Valvani alleging he fraudulently made $25 million by getting advance information about US Food and Drug Administration approvals of generic drug applications

Drugmakers cash in on  health supplement segment

Drugmakers cash in on health supplement segment

Rediff.com22 Aug 2008

Nutraceuticals, consisting of dietary supplements and functional foods with curative or nutritional benefits, are estimated to have a sales of $190 billion globally by 2010. India's food supplement and health food market is estimated currently at about $400 million. The country already has a clutch of established players focussing in this segment such as Avesthagen, Himalaya and Sami Labs.

India acts to repair reputation as drugs exporter

India acts to repair reputation as drugs exporter

Rediff.com7 May 2014

As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.

What ails India's healthcare system

What ails India's healthcare system

Rediff.com2 Dec 2009

The Indian healthcare system currently combines the worst features of the public and private models.

Ranbaxy launches GSK's blockbuster drug in US

Ranbaxy launches GSK's blockbuster drug in US

Rediff.com27 Nov 2009

Ranbaxy has six-month exclusive marketing right to anti-herpes Valtrex.

Sun Pharma settles dispute with Astra Zeneca

Sun Pharma settles dispute with Astra Zeneca

Rediff.com4 Aug 2009

Under the agreement, MedImmune has granted Sun Pharma a licence to certain patents, permitting Sun Pharma to continue marketing its generic version of Ethyol in the US.

How to have an EXCITING travel adventure!

How to have an EXCITING travel adventure!

Rediff.com13 Dec 2019

The new-age traveler is no longer into ticking a checklist of must-see spots on his holiday. He is ready to pay a premium to experience culture, crafts and culinary delights of the local populace

Pharma: Remove duties on life saving drugs

Pharma: Remove duties on life saving drugs

Rediff.com30 Jun 2009

The pharma sector seeks removal of Excise Duty on Bulk drugs & Formulation of Anti-AIDS, Anti-Cancer, Anti-TB and other life-saving drugs

India's FDI during Apr-Feb jumps to $37.53 billion

India's FDI during Apr-Feb jumps to $37.53 billion

Rediff.com2 May 2016

Services attracted the most FDI during the first eleven months period of 2015-16.

Indian refiners beat global peers in margin game

Indian refiners beat global peers in margin game

Rediff.com13 Feb 2009

Refining margin is the difference in prices of crude oil and finished products. More exposure to diesel behind less fall in Indian refining margins.

Global drug majors slow R&D offshoring to India

Global drug majors slow R&D offshoring to India

Rediff.com12 Feb 2009

New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India.